Diagnosing and Managing C difficile Infections

In this downloadable slideset, review key data and guideline recommendations surrounding the diagnosis and management of challenging C difficile infections.
CiarĂ¡n P. Kelly, MD
Format: Microsoft PowerPoint (.ppt)
File Size: 603 KB
Released: November 21, 2018

Acknowledgements

Provided by Postgraduate Institute for Medicine
PIM Logo

Postgraduate Institute for Medicine
304 Inverness Way South, Suite 100
Englewood, CO 80112

Allison Hughes, CCMEP, Program Manager
(303) 799-1930
(303) 858-8842 (Fax)
ahughes@pimed.com
www.pimed.com

Supported by an educational grant from
Merck & Co., Inc.

Related Content

High-dose trivalent influenza vaccine comparable to standard-dose quadrivalent vaccine in deaths or cardiopulmonary hospitalizations in high-risk CV disease; AHA results reported by CCO

Released: November 20, 2020

Vericiguat VICTORIA subgroup analysis from AHA, as reported by CCO

Released: November 18, 2020

Ferric carboxymaltose reduced risk of subsequent hospitalization in iron-deficient acute heart failure: AFFIRM-AHF data from AHA 2020, by CCO

Released: November 18, 2020

Omecamtiv mecarbil reduced time to first heart failure event or cardiovascular death in patients with heart failure with reduced ejection fraction: GALACTIC-HF data from AHA 2020 as reported by CCO

Released: November 16, 2020

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue